Achhra, Amit C <br/><br/>
Moving away from Ritonavir, Abacavir, Tenofovir, and Efavirenz (RATE)--agents that concern prescribers and patients: a feasibility study and call for a trial.  [electronic resource] 

 -  PloS one  2014 
 - e99530 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0099530  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenine--administration & dosage<br/>Adult<br/>Alkynes<br/>Anti-HIV Agents--administration & dosage<br/>Benzoxazines--administration & dosage<br/>Clinical Trials as Topic<br/>Cyclohexanes--administration & dosage<br/>Cyclopropanes<br/>Dideoxynucleosides--administration & dosage<br/>Feasibility Studies<br/>Female<br/>Humans<br/>Male<br/>Maraviroc<br/>Middle Aged<br/>Organophosphonates--administration & dosage<br/>Ritonavir--administration & dosage<br/>Tenofovir<br/>Triazoles--administration & dosage